Novel immunostimulatory phosphodiester oligodeoxynucleotides with CpT sequences instead of CpG motifs

Molecular Immunology

Volumn 48, Issue 12-13, 2011, Pages 1494-1504

  Kim, Dongbum ^a   Jung, Jinwon ^b   Lee, Younghee ^c   Kwon, Hyung Joo ^a  

^a Hallym University   (South Korea)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c Chungbuk National University   (South Korea)

Author keywords

Bacterial DNA; CT ODN; Innate immunity; Liposome encapsulation; TLR9

Indexed keywords

BACTERIAL DNA; IMMUNOGLOBULIN G; INTERLEUKIN 8; OLIGODEOXYNUCLEOTIDE PHOSPHOROTHIOATE;

ARTICLE; BACTERIAL CHROMOSOME; CONTROLLED STUDY; CPG ISLAND; CYTOKINE PRODUCTION; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOSTIMULATION; INNATE IMMUNITY; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; B-LYMPHOCYTES; BASE SEQUENCE; CELL LINE; CYTOKINES; DINUCLEOSIDE PHOSPHATES; DNA, BACTERIAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; HUMANS; IMMUNIZATION; IMMUNOGLOBULIN G; INTERLEUKIN-8; LIPOSOMES; MICE; MICE, INBRED BALB C; OLIGODEOXYRIBONUCLEOTIDES; PHOSPHOROTHIOATE OLIGONUCLEOTIDES; PROMOTER REGIONS, GENETIC; STAPHYLOCOCCUS AUREUS; TOLL-LIKE RECEPTOR 9;

BACTERIA (MICROORGANISMS); STAPHYLOCOCCUS AUREUS;

EID: 79957851142     PISSN: 01615890     EISSN: 18729142     Source Type: Journal    
DOI: 10.1016/j.molimm.2011.04.009     Document Type: Article

References (41)

1. Aderem A., Ulevitch R.J. Toll-like receptors in the induction of the innate immune response. Nature 2000, 406:782-787.
2. Anderson K.V. Toll signaling pathways in the innate immune response. Curr. Opin. Immunol. 2000, 12:13-19.
3. Akira S., Uematsu S., Takeuchi O. Pathogen recognition and innate immunity. Cell 2006, 124:783-801.
4. Ballas Z.K., Rasmussen W.L., Krieg A.M. Induction of NK activity in murine and human cells by CpG motifs in oligodeoxynucleotides and bacterial DNA. J. Immunol. 1996, 157:1840-1845.
5. Ballas Z.K., Krieg A.M., Warren T., Rasmussen W., Davis H.L., Waldschmidt M., Weiner G.J. Divergent therapeutic and immunologic effects of oligodeoxynucleotides with distinct CpG motifs. J. Immunol. 2001, 167:4878-4886.
6. Broide D., Schwarze J., Tighe H., Gifford T., Nguyen M.D., Malek S., Van Uden J., Martin-Orozco E., Gelfand E.W., Raz E. Immunostimulatory DNA sequences inhibit IL-5, eosinophilic inflammation, and airway hyperresponsiveness in mice. J. Immunol. 1998, 161:7054-7062.
7. Deng G.M., Nilsson I.M., Verdrengh M., Collins L.V., Tarkowski A. Intra-articularly localized bacterial DNA containing CpG motifs induces arthritis. Nat. Med. 1999, 5:702-705.
8. Gregoriadis G., Saffie R., Hart S.L. High yield incorporation of plasmid DNA within liposomes: effect on DNA integrity and transfection efficiency. J. Drug Target 1996, 3:469-475.
9. Hacker H., Vabulas R.M., Takeuchi O., Hoshino K., Akira S., Wagner H. Immune cell activation by bacterial CpG-DNA through myeloid differentiation marker 88 and tumor necrosis factor associated factor 6. J. Exp. Med. 2000, 192:595-600.
10. Heikenwalder M., Polymenidou M., Junt T., Sigurdson C., Wagner H., Akira S., Zinkernagel R., Aguzzi A. Lymphoid follicle destruction and immunosuppression after repeated CpG oligodeoxynucleotide administration. Nat. Med. 2004, 10:187-192.
11. Hemmi H., Takeuchi O., Kawai T., Kaisho T., Sato S., Sanjo H., Matsumoto M., Hoshino K., Wagner H., Takeda K., Akira S. A Toll-like receptor recognizes bacterial DNA. Nature 2000, 408:740-745.
12. Janeway C.A., Medzhitov R. Introduction: the role of innate immunity in the adaptive immune response. Semin. Immunol. 1998, 10:349-350.
13. Kim D., Rhee J.W., Kwon S., Sohn W.J., Lee Y., Kim D.W., Kim D.S., Kwon H.J. Immunostimulation and anti-DNA antibody production by backbone modified CpG-DNA. Biochem. Biophys. Res. Commun. 2009, 379:362-367.
14. Kim D., Rhee J.W., Kwon S., Kim Y.E., Choi S.Y., Park J., Lee Y., Kwon H.J. Enhancement of immunomodulatory activity by liposome-encapsulated natural phosphodiester bond CpG-DNA in a human B cell line. BMB Rep. 2010, 43:250-256.
15. Klinman D.M., Yi A.K., Beaucage S.L., Conover J., Krieg A.M. CpG motifs present in bacteria DNA rapidly induce lymphocytes to secrete interleukin 6, interleukin 12, and interferon-γ. Proc. Natl. Acad. Sci. U.S.A. 1996, 93:2879-2883.
16. Krieg A.M. CpG motifs in bacterial DNA and their immune effects. Annu. Rev. Immunol. 2002, 20:709-760.
17. Krieg A.M. Therapeutic potential of Toll-like receptor 9 activation. Nat. Rev. Drug Discov. 2006, 5:471-484.
18. Krieg A.M., Yi A.K., Matson S., Waldschmidt T.J., Bishop G.A., Teasdale R., Koretzky G.A., Klinman D.M. CpG motifs in bacterial DNA trigger direct B-cell activation. Nature 1995, 374:546-549.
19. Kwon H.J., Lee K.W., Yu S.H., Han J.H., Kim D.S. NF-κB-dependent regulation of tumor necrosis factor-α gene expression by CpG-oligodeoxynucleotides. Biochem. Biophys. Res. Commun. 2003, 311:129-138.
20. Lee K.W., Jung J., Lee Y., Kim T.Y., Choi S.Y., Park J., Kim D.S., Kwon H.J. Immunostimulatory oligodeoxynucleotide isolated from genome wide screening of Mycobacterium bovis chromosomal DNA. Mol. Immunol. 2006, 43:2107-2118.
21. Lee K.W., Lee Y., Kim D.S., Kwon H.J. Direct role of NF-κB activation in Toll-like receptor-triggered HLA-DRA expression. Eur. J. Immunol. 2006, 36:1254-1266.
22. Lee K.W., Kim D.S., Kwon H.J. CG sequence- and phosphorothioate backbone modification-dependent activation of the NF-κB-responsive gene expression by CpG-oligodeoxynucleotides in human RPMI 8226 B cells. Mol. Immunol. 2004, 41:955-964.
23. Liang H., Nishioka Y., Reich C.F., Pisetsky D.S., Lipsky P.E. Activation of human B cells by phosphorothioate oligodeoxynucleotides. J. Clin. Invest. 1996, 98:1119-1129.
24. Lutz M.B., Schnare M., Menges M., Rössner S., Röllinghoff M., Schuler G., Gessner A. Differential functions of IL-4 receptor types I and II for dendritic cell maturation and IL-12 production and their dependency on GM-CSF. J. Immunol. 2002, 169:3574-3580.
25. Magnusson M., Tobes R., Sancho J., Pareja E. Natural DNA repetitive extragenic sequences from Gram-negative pathogens strongly stimulate TLR9. J. Immunol. 2007, 179:31-35.
26. Messina J.P., Gilkeson G.S., Pisetsky D.S. Stimulation of in vitro murine lymphocyte proliferation by bacterial DNA. J. Immunol. 1991, 147:1759-1764.
27. Pisetsky D.S. The immunologic properties of DNA. J. Immunol. 1996, 156:421-423.
28. Rutz M., Metzger J., Gellert T., Luppa P., Lipford G.B., Wagner H., Bauer S. Toll-like receptor 9 binds single-stranded CpG-DNA in a sequence- and pH-dependent manner. Eur. J. Immunol. 2004, 34:2541-2550.
29. Stein C.A., Subasinghe C., Shinozuka K., Cohen J.S. Physicochemical properties of phosphorothioate oligodeoxynucleotides. Nucleic Acids Res. 1988, 16:3209-3221.
30. Sparwasser T., Koch E.S., Vabulas R.M., Heeg K., Lipford G.B., Ellwart J.W., Wagner H. Bacterial DNA and immunostimulatory CpG oligonucleotides trigger maturation and activation of murine dendritic cells. Eur. J. Immunol. 1998, 28:2045-2054.
31. Sparwasser T., Hultner L., Koch E.S., Luz A., Lipford G.B., Wagner H. Immunostimulatory CpG-oligodeoxynucleotides cause extramedullary murine hemopoiesis. J. Immunol. 1999, 162:2368-2374.
32. Takaoka A., Wang Z., Choi M.K., Yanai H., Negishi H., Ban T., Lu Y., Miyagishi M., Kodama T., Honda K., Ohba Y., Taniguchi T. DAI (DLM-1/ZBP1) is a cytosolic DNA sensor and an activator of innate immune response. Nature 2007, 448:501-505.
33. Takeda K., Kaisho T., Akira S. Toll-like receptors. Annu. Rev. Immunol. 2003, 21:335-376.
34. Tokunaga T., Yamamoto H., Shimada S., Abe H., Fukuda T., Fujisawa Y., Furutani Y., Yano O., Kataoka T., Sudo T., Makiguchi N., Suganuma T. Antitumor activity of deoxyribonucleic acid fraction from Mycobacterium bovis BCG I. Isolation, physicochemical characterization, and antitumor activity. J. Natl. Cancer Inst. 1984, 72:955-962.
35. Tsujimoto H., Efron P.A., Matsumoto T., Ungaro R.F., Abouhamze A., Ono S., Mochizuki H., Moldawer L.L. Maturation of murine bone marrow-derived dendritic cells with poly(I:C) produces altered TLR-9 expression and response to CpG-DNA. Immunol. Lett. 2006, 107:155-162.
36. Xu Y., Zhan Y., Lew A.M., Naik S.H., Kershaw M.H. Differential development of murine dendritic cells by GN-CSF versus Flt3 ligand has implications for inflammation and trafficking. J. Immunol. 2007, 179:7577-7584.
37. Yamamoto S., Yamamoto T., Kataoka T., Kuramoto E., Yano O., Tokunaga T. Unique palindromic sequences in synthetic oligonucleotides are required to induce IFN and augment IFN-mediated natural killer activity. J. Immunol. 1992, 148:4072-4076.
38. Yasuda K., Yu P., Kirschning C.J., Schlatter B., Schmitz F., Heit A., Bauer S., Hochrein H., Wagner H. Endosomal translocation of vertebrate DNA activates dendritic cells via TLR9-dependent and -independent pathways. J. Immunol. 2005, 174:6129-6136.
39. Zhao Q., Matson S., Herrera C.J., Fisher E., Yu H., Krieg A.M. Comparison of cellular binding and uptake of antisense phosphodiester, phosphorothioate, and mixed phosphorothioate and methylphosphonate oligonucleotides. Antisense Res. Dev. 1993, 3:53-66.
40. Zhao Q., Waldschmidt T., Fisher E., Herrera C.J., Krieg A.M. Stage-specific oligonucleotide uptake in murine bone marrow B-cell precursors. Blood 1994, 84:3660-3666.
41. Zimmermann S., Egeter O., Hausmann S., Lipford G.B., Rocken M., Wagner H., Heeg K. CpG oligodeoxynucleotides trigger protective and curative Th1 responses in lethal murine leishmaniasis. J. Immunol. 1998, 160:3627-3630.